Condition
Progression-Free Survival clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Progression-Free Survival clinical trials that are recruiting, at sites in 3 countries (most in China (3), Taiwan (1), United States (1)). By phase: Phase 2 (2), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Progression-Free Survival clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Using Metformin with FOLFIRI chemotherapy for metastatic colorectal cancer | Phase 2 | Kaohsiung City | Recruiting | Feb 13, 2025 |
| Using olanzapine to improve survival in patients with advanced gastrointestinal and lung cancer | Phase 3 | Xining, Qinghai | Recruiting | Mar 29, 2024 |
| New target method for treating high-grade glioma patients | — | Guangzhou | Recruiting | Jan 22, 2024 |
| Long-term follow-up for patients treated with CAR T cells | — | Boston, Massachusetts | Recruiting | Aug 27, 2021 |
| Using Imatinib Mesylate before surgery for gastrointestinal stromal tumors | Phase 2 | Hangzhou, Zhejiang | Recruiting | Jun 22, 2021 |
All recruiting trials (5)
-
Using Metformin with FOLFIRI chemotherapy for metastatic colorectal cancer
This study is testing if adding Metformin to FOLFIRI chemotherapy can help people with metastatic colorectal cancer live longer and feel better.
-
Using olanzapine to improve survival in patients with advanced gastrointestinal and lung cancer
This study is testing if adding the medication olanzapine to regular cancer treatment and nutritional advice can help people with advanced gastrointestinal and lung cancers live longer and feel better.
-
New target method for treating high-grade glioma patients
This study tests a new way of targeting radiation treatment for patients with high-grade glioma to see if it helps them live longer without their cancer getting worse and reduces side effects compared to the standard method.
-
Long-term follow-up for patients treated with CAR T cells
This study looks at how well CAR T cell therapy works and its long-term safety for patients up to 15 years after their treatment.
-
Using Imatinib Mesylate before surgery for gastrointestinal stromal tumors
This study is testing if taking imatinib mesylate before surgery can help people with high-risk gastrointestinal stromal tumors have better outcomes and live longer.
Related topics
Quick answers
How many Progression-Free Survival clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (3 trials), Taiwan (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.